Westbrook, Maine-based IDEXX Laboratories, Inc. (IDXX) develops, manufactures, and distributes products for the companion ...

The stock's fall snapped a two-day winning streak.

How much a stock's price changes over time is important for most investors, since price performance can both impact your investment portfolio and help you compare investment results across sectors and ...

IDEXX Laboratories has approved a Nonqualified Deferred Compensation Plan allowing select management and high-earning employees to defer parts of their compensation.

(RTTNews) - IDEXX Laboratories, Inc. (IDXX) increased 2023 EPS outlook to $9.64 - $9.90, a year-over-year increase of 20% - 23% as reported and 24% - 27% on a comparable basis, including ...

IDEXX Laboratories has continued to underperform the S&P 500 over the past year, yet analysts remain moderately bullish on the stock’s prospects.

IDEXX Laboratories has outperformed the broader market and continues to show strong growth in its diagnostic products and services for pets. The company is shifting towards recurring revenue ...

IDEXX Laboratories beat Wall Street estimates for fourth-quarter revenue and profit on Monday, helped by strong demand for its veterinary diagnostic services despite persistent weakness in visits ...

IDEXX Laboratories trimmed its annual revenue forecast for the third time on Thursday, as the animal health diagnostic equipment maker sees fewer visits to veterinary clinics from pet owners.

IDEXX sees revenue for the full year to be between $3.93 billion and $4.04 billion, the midpoint of which is above analysts' estimates of $3.97 billion, according to LSEG data. Piper Sandler ...